Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma

Published:2009-07 Issue:3 Volume:218 Page:380-390
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Strickland Laura A,Ross Jed,Williams Simon,Ross Sarajane,Romero Maria,Spencer Susan,Erickson Rich,Sutcliffe Julie,Verbeke Caroline,Polakis Paul,van Bruggen Nicholas,Koeppen Hartmut

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference44 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Pancreatic cancer;Li;Lancet,2004

3. Molecular therapy in pancreatic adenocarcinoma;MacKenzie;Lancet Oncol,2004

4. Novel therapies for pancreatic adenocarcinoma;Pino;Curr Gastroenterol Rep,2004

5. Redefined nomenclature for members of the carcinoembryonic antigen family;Beauchemin;Exp Cell Res,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiomics2Targets identifies targets from cancer cohorts profiled with transcriptomics, proteomics, and phosphoproteomics;Cell Reports Methods;2024-08

2. Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker;F1000Research;2024-04-04

3. Delivery of a BET protein degrader via a CEACAM6-targeted antibody–drug conjugate inhibits tumour growth in pancreatic cancer models;Nature Communications;2024-03-11

4. HSV-1 Oncolytic Virus Targeting CEACAM6-Expressing Tumors Using a Bispecific T-Cell Engager;2023-01-02

5. Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis;Therapeutic Advances in Medical Oncology;2022-01